Judith L Swain insider trades

Open-market stock purchases and sales by Judith L Swain, Director at Lexicon Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 30, 2010.

Recent trades

DateStockTradeValue
Jun 3, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—
May 1, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—
May 1, 2026LXRX Lexicon Pharmaceuticals, IncBought (not open market)—

Companies traded

  • LXRX Lexicon Pharmaceuticals, Inc: other filings, last Jun 3, 2026
  • RXDX Prometheus Biosciences, Inc: other filings, last Jun 16, 2023

Get free alerts when Judith L Swain files a new trade →